Abstract
The angiogenic process is central in the pathogenesis of various diseases. The in vitro and in vivo monitoring of the neovascular process is essential for the development and evaluation of angiogenesis inhibitors or stimulators. Since no single method exists that can assess angiogenesis in a robust, reliable, and reproducible fashion, researchers often use a combination of assays to circumvent this problem. The experimental details of the most commonly in vitro, ex vivo, and in vivo assays are presented here.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Carmeliet, P. and Jain R.K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249–257.
Carolyn A. Staton, Malcolm W. R. Reed and Nicola J. Brown. (2009) A critical analysis of current in vitro and in vivo angiogenesis assays. Int. J. Exp. Path. 90, 195–221.
Bishop, E.T., Bell, G.T., Bloor, S. Broom, I.J., Hendry, N.F., and Wheatley, D.N. (1999) An in vitro model of angiogenesis : basic features. Angiogenesis 3, 335–344.
Donovan, D., Brown, N.J., Bishop, E.T., Lewis C.E. (2001) Comparison of three in vitro human “angiogenesis” assays with capillaries formed in vivo, Angiogenesis 4, 113–121.
Tolboom, T.C., Huizinga, T.W. In vitro matrigel fibroblast invasion study Meth. Mol. Med. 135, 413–421.
Lochter, A., Srebrow, A., Sympson, C.J., Terracio, N., Werb, Z., and Bissell, M.J. (1997) Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J. Biol. Chem. 272, 5007–5015.
Knutson, J.R., Iida, J., Fields, G.B., and McCarthy, J.B. (1996) CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol. Biol.Cell. 7, 383–396.
Setsuko, K. (2000) Chambers In vitro invasion assays. Meth. Mol. Med. 39, 179–185.
Storgard, C., Mikolon, D., and Stupack, D.G. (2004) Angiogenesis assays in the chick CAM. Meth. Mol. Biol. 294, 123–136.
Mydlo, J. (2001) Angiogenesis assays. Meth. Mol. Med. 53, 265–275.
Nguyen, M., Shing, Y., and Folkman, J. (1994) Quantitation of angiogenesis and anti-angiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47, 31–38.
Cockerill, G. W., Gamble, J. R., and Vadas, M. A. (1995) Angiogenesis: models and modulators. Int. Rev. Cytol. 159, 113–160.
Nicosia, R. F. and Ottinetti, A. (1990) Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab.Invest. 63, 115–122.
O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328.
Ferrara, N. and Alitalo, K. (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5, 1359–1364.
Go, R.S. and Owen, W.G. (2000) Very low concentrations of rat plasma and rat serum stimulate angiogenesis in the rat aortic ring assay. Fibrinolysis Proteol. 19 (Suppl 1), 45.
Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. G., and Martin, G. R. (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519–528.
Grant, D. S., Kinsella, J. L., Fridman, R., Auerbach, R., Piasecki, B. A., Yamada, Y., Zain, M., and Kleinman, H. K. (1992) Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J. Cell Physiol. 153, 614–625.
Kibbey, M. C., Corcoran, M. L., Wahl, L. M., and Kleinman, H. K. (1994) Laminin SIKVAV peptide-induced angiogenesis in vivo is potentiated by neutrophils. J. Cell Phys. 160, 185–193.
Malinda, K. (2008) In vivo matrigel migration and angiogenesis assay, Meth. Mol. Biol. 467, 287–294.
Stechschulte, S.U., Joussen, A.M., von Recum, H.A., Poulaki, V., Moromizato, Y., Yuan, J., D’Amato, R.J., Kuo, C. and Adamis, A.P. (2001) Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest. Ophthalmol. Vis. Sci. 42, 1975–1979.
Joussen, A.M., Poulaki, V., Mitsiades, N., Stechschulte, S.U., Kirchhof, B., Dartt, D.A., Fong, G.H., Rudge, J., Wiegand, S.J., Yancopoulos, G.D. and Adamis, A.P. (2003) VEGF-dependent conjunctivalization of the corneal surface. Invest. Ophthalmol. Vis. Sci. 44, 117–123.
Smith, L.E., Wesolowski, E., McLellan, A., Kostyk, S.K., D’Amato, R., Sullivan, R. and D’Amore, P.A. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101–111.
Kociok, N., Krohne, T.U., Poulaki, V. and Joussen, A.M. (2007) Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 245, 258–266.
Maier, A.K., Kociok, N., Zahn, G., Vossmeyer, D., Stragies, R., Muether, P.S. and Joussen, A.M. (2007) Modulation of hypoxia-induced neovascularization by JSM6427, an integrin alpha5beta1 inhibiting molecule. Curr. Eye Res. 32, 801–812.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Poulaki, V. (2011). Angiogenesis Assays. In: Cree, I. (eds) Cancer Cell Culture. Methods in Molecular Biology, vol 731. Humana Press. https://doi.org/10.1007/978-1-61779-080-5_28
Download citation
DOI: https://doi.org/10.1007/978-1-61779-080-5_28
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-079-9
Online ISBN: 978-1-61779-080-5
eBook Packages: Springer Protocols